The RK-251, seen in the news recently, is about: |ForumIAS

[A] A new radiotherapy technique for treating brain tumours

[B] A “smart” anti-cancer drug designed to selectively target tumour cells while sparing healthy cells

[C] An AI-based diagnostic tool for detecting early-stage cancers

[D] A gene-editing therapy for treating inherited cancers

Answer: B

Notes:

Explanation: A “smart” anti-cancer drug designed to selectively target tumour cells while sparing healthy cells

RK-251 is a novel preclinical anti-cancer drug candidate developed through collaborative research involving IASST and IIT Guwahati. It is designed to remain relatively inactive in normal tissues but become activated in the reactive oxygen species (ROS)-rich environment of cancer cells, releasing the anticancer compound NBDHEX. It has shown promising activity against triple-negative breast cancer cells in preclinical studies.

Source: DD News